⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Replimune Group, Inc.

$13.30
+0.07 (+0.53%)

Market Capitalization:

$1.25B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Replimune Group Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

+0.06(+0.45%)
Open$13.24
Close$13.30
Low$13.21
Low Change-0.03 (-0.23%)
High$13.39
High Change+0.15 (+1.13%)
Range$0.18
Volume530.168K
Dollar Volume$7.05M

Regular Trading Hours Yesterday

-1.24(-8.57%)
Open$14.47
Close$13.23
Low$13.21
Low Change-1.26 (-8.71%)
High$14.47
High Change+0.00 (+0.00%)
Range$1.26
Volume3.096M
Dollar Volume$40.97M

Premarket Yesterday

+0.02(+0.14%)
Open$14.43
Close$14.45
Low$14.30
Low Change-0.13 (-0.90%)
High$14.49
High Change+0.06 (+0.42%)
Range$0.19
Volume3.843K
Dollar Volume$55.53K

Replimune Group Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Replimune Group Moving Averages

5 Day Moving Average (SMA5)$14.55
10 Day Moving Average (SMA10)$15.08
20 Day Moving Average (SMA20)$15.06
50 Day Moving Average (SMA50)$12.54
100 Day Moving Average (SMA100)$9.38
200 Day Moving Average (SMA200)$8.69

Replimune Group Statistics

Average Volume (30 Days)5.83M
P/E Ratio (Current)-4.59
EPS (Current)-$3.15
Dividend Yield0.00%
Free Cash Flow-$280.55M
Cash Ratio4.83
Current Ratio5.23
Quick Ratio5.23
Debt to Equity1.03
Enterprise Value$1.28B
EV to EBITDA-4.36
EV to Sales
Price to Book12.89
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-1.18%
Return on Equity-2.81%

Replimune Group Stock Splits

There has been 1 stock split for Replimune Group (REPL). The stock split occured on December 1, 2010 and increased the outstanding shares at a ratio of 1:15.

DateTypeRatio
Dec 1, 2010Forward1:15

Replimune Group Dividends

There have been no dividends for Replimune Group (REPL).